CHESTERFIELD, Mo., June 2, 2012 /PRNewswire/ -- Reliv International (RELV) has incorporated a breakthrough ingredient into its patented, clinically proven GlucAffect ® formula.
The addition of LunaRich comes less than a month after the CDC published findings from the National Health and Nutrition Examination Survey indicating metabolic syndrome continues to rise among Americans.
Fighting an EpidemicMetabolic syndrome — a cluster of symptoms including high blood sugar, obesity and cardiovascular problems — has reached epidemic proportions. According to the American Heart Association, 47 million Americans now have metabolic syndrome. The syndrome afflicts 40 percent of people in their sixties and seventies. That number is expected to rise along with our aging population. The CDC also predicts that one-third of Americans will have diabetes if current trends continue.In addition, a recent CDC study published in Pediatrics shows the epidemic isn't limited to older adults. Obesity in teens has skyrocketed in the past decade — 23 percent of teens are now classified as diabetic or prediabetic. A person with metabolic syndrome is twice as likely to develop heart disease and five times more likely to develop diabetes. Other silent symptoms include eye, kidney and nervous system damage over time. Metabolic syndrome typically includes three or more symptoms:
- waistline of 40+ inches for men or 35+ inches for women
- high blood pressure, or on blood pressure medication
- high triglycerides
- high blood sugar or type 2 diabetes
- low levels of HDL (good) cholesterol
Balancing Blood SugarThe solution for metabolic syndrome lies in a three-pronged approach of balancing blood sugar, losing weight and improving cholesterol. Blood sugar management and weight loss go hand-in-hand. Blood sugar levels can effect hunger feelings and energy levels. When blood sugar and insulin levels drop too low, we feel hungry. Weight loss is easier if blood sugar is continuously balanced.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV